UnitedHealth Group Inc (UNH) (Q3FY23) – Focusing on value-based care for a healthier future

Highlights of the report

UnitedHealth- The medical loss ratio (MLR) is the share of total healthcare premiums spent on medical claims and efforts to improve the quality of care While revenue grew 14%, the medical care ratio increased to 82.3% from 81.6% last year due to higher outpatient care costs. If medical cost inflation persists, it could put pressure on earnings going forward.

CrispIdea equity reports provide valuable insights to investors who may be individuals and organizations involved in the world of finance and investment like private equity houses, broking firms, hedge funds, investment advisory firms, mutual funds, banks and corporations. This research report is useful for M&A, business & investment analysis to all students and researchers also.


CrispIdea equity reports include basic financials, strategic analysis, competitive landscape assessments, stock performance, stock analysis and future growth potential evaluation. CrispIdea utilizes a proprietary blend of fundamental and technical analysis, offering a unique perspective. Reports present clear investment recommendations (“BUY,” “HOLD,” or “SELL”).


Our established reputation and track record advocates that our research carries weight within the investment community. Do connect with us, if you are looking for customized research, equity valuation, recommendation, analysis and market recommendation for any specific company, sector and industry.

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers

UnitedHealth revenue increased from $80.89bn in Q3FY22 to $92.36bn in Q3FY23. EBITDA increased from $9.88bn in Q3FY22 to $11.52bn in Q3FY23

Over the past 3 months, UnitedHealth stock generated returns of 7% where the stock price surged from $506.69 in Aug 15, 2023 to $542.57 in Nov 13, 2023.



– Enterprise Value
– CrispIdea Forecast
– Economic Value Added Analysis
– Discounted Cash Flow Analysis
– P/E Analysis
– Peer Valuation
– CrispIdea Forecast Relative to Consensus
– Consensus History and Surprise
– Consensus Momentum

Actual & Historical Performance

– Income Statement
– Balance Sheet
– Cash Flow
– 10 Year Historical Performance
– Ratio Analysis
– Du Pont Analysis
– ROIC & ROCE Analysis
– Segment Performance
– Key Metrics
– M&A Deals

Peer Performance

– Summary
– Profitability
– Growth
– Price Performance


Stock Price Performance

Crispidea Coverage

Report details

UnitedHealth Group Inc (UNH) (Q3FY23) – Focusing on value-based care for a healthier future



Company Reports

Sector Reports